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Hemolytic uremic syndrome (HUS), principally caused by shiga toxins (Stxs), is
associated with Shiga toxin-producing Escherichia coli (STEC) infections. We previously
reported Stx2 expression by host cells in vitro and in vivo. As the genes encoding the two
Stx subunits are located in bacteriophage genomes, the aim of the current study was
to evaluate the role of bacteriophage induction in HUS development in absence of an E.
coli O157:H7 genomic background. Mice were inoculated with a non-pathogenic E. coli
strain carrying the lysogenic bacteriophage 933W (C6008933W), and bacteriophage
excision was induced by an antibiotic. The mice died 72 h after inoculation, having
developed pathogenic damage typical of STEC infection. As well as renal and intestinal
damage, markers of central nervous system (CNS) injury were observed, including
aberrant immunolocalization of neuronal nuclei (NeuN) and increased expression of glial
fibrillary acidic protein (GFAP). These results show that bacteriophage 933Wwithout an E.
coli O157:H7 background is capable of inducing the pathogenic damage associated with
STEC infection. In addition, a novel mouse model was developed to evaluate therapeutic
approaches focused on the bacteriophage as a new target.
Keywords: bacterio(phages), hemolytic uremic syndrome, Shiga toxin (Stx), Shiga toxigenic E. coli (STEC), animal
model
INTRODUCTION
During infection with Shiga toxin-producing E. coli (STEC), which harbors the temperate
bacteriophage 933W (Plunkett et al., 1999), phages undergo excision and replication and Shiga
toxin (Stx) is expressed and released. The free bacteriophages are then able to infect other
susceptible bacteria in the gut, exacerbating bacteriophage replication and Stx production (Muniesa
and Schmidt, 2014). Bacteriophage excision is linked to the SOS response of bacteria (Kimmitt
et al., 2000). Several antibiotics, such as mitomycin C and quinolones, including ciprofloxacin, are
contraindicated in STEC infections, because at antimicrobial levels above those required to inhibit
bacterial replication they cause DNA damage. The subsequent SOS response has the undesired side
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effect of simultaneously triggering phage production and
expression of stx2 genes. Additionally, it has been reported that
an STEC strain mutated in the cleavage mechanismwas unable to
induce renal disease and lethality in a mouse model (Tyler et al.,
2013).
STEC strains present several pathogenic properties that
increase injury in the gut, including the typical A/E lesion,
which is produced by several proteins encoded in a pathogenicity
island called LEE (Locus of Enterocyte Effacement) (Kaper, 1998;
Sperandio et al., 1998). In a previous study on the role of Stx-
encoding bacteriophages in STEC infection, we showed that the
use of chitosan as an anti-bacteriophage agent led to a decrease
in the mortality rate of infected mice (Amorim et al., 2014).
In the current work, mice infected with non-pathogenic E. coli
C600, lysogenic for the Stx bacteriophage 933W, developed renal,
intestinal and brain damage typical of STEC infection, indicating
that the pathogenic characteristics of the STEC strain, although
important, are not essential for the development of hemolytic
uremic syndrome (HUS). These results highlight the importance
of bacteriophage 933W in HUS development, supporting the
hypothesis that anti-bacteriophage agents can provide a new
therapeutic approach against STEC infections.
MATERIALS AND METHODS
Strains and Inoculums Preparation
E. coli C6008933W and E. coli C600 were grown in LB media for
16 h at 37◦C in agitation. The overnight cultures were centrifuged
at 3,000 × g for 15min. The pellet was washed and resuspended
in sucrose 20% at a dose of 2× 108 CFU/100 µl/mouse.
Bacteriophage induction was done by treatment with a mix of
ciprofloxacin (100 µg/mouse) and mitomycin C (5 µg/mouse),
which was intragastrically inoculated 30min post-infection.
Bacterial Growth Curve
Strains were grown overnight (ON) in LB medium at 37◦C with
agitation. The ON cultures were diluted 1:100 in LB in 250ml
Erlenmeyer flasks with a final volume of 50ml. Samples were
taken every hour for 6 h and ON (T0,T1,T2,T3,T4,T5,T6,TON)
and the optical density at 600 nm of each sample was measured.
Anti-Bacteriophage Polyclonal Antibodies
Balb/c mice were immunized with inactivated bacteriophages.
Bacteriophages were prepared by formalin treatment. Briefly,
bacteriophages were incubated overnight in 2% formalin
and then dialyzed extensively against PBS. Bacteriophages
were purified as previously reported (Del Cogliano et al.,
2017). Mice were immunized with bacteriophages emulsified
in Freund’s complete (initial immunization) or incomplete
(subsequent immunizations) adjuvant. Mice received inactivated
bacteriophages three times at biweekly intervals. Sera were
obtained 15 and 30 days post immunization, tittered and kept at
−20◦C.
Mice Infection
C57BL/c mice were bred in the animal facility of the Institute
of Experimental Medicine, (IMEX), Academia Nacional de
Medicina, Buenos Aires, Argentina. Mice (17–20 days of age,
8–11 g of body weight) were maintained under a 12-h light–dark
cycle at 22± 2C and fed with standard diet and water ad libitum.
Mice were used immediately after weaning.
The experiments performed herein were approved by the
IMEX Animal Care Committee in accordance with the principles
set forth in the Guide for the Care and Use of Laboratory Animals
(National Institute of Health, 1985). After 4 h of starvation,
weaned mice were divided into two groups. One group was
inoculated intragastrically via a stainless steel canula (model
7.7.1, 0.38mm 9 22G) (Harvard Apparatus, Holliston, MA) with
a single dose of 100 µl of E. coli C600:933W strain (2 × 108
CFU/100 µl/mice). The control group was inoculated with E. coli
C600 strain following the same approach.
Two doses of antibiotics were administered at 5 and 30min
after infection with a mix of 100 µg of ciprofloxacin (Roemmers)
and 5 µg of mitomycin C (Sigma Aldrich). Food and water were
provided to mice ad libitum 4 h after inoculation.
Histological Studies
For histological analysis, mice were sacrificed 72 h after infection
and subjected to necropsy. Mice were transcardially perfused
with PBS in order to completely remove the blood, followed by
5% buffer-formaldehyde. Kidneys, small and large intestines and
brains were removed, sectioned, fixed in 5% buffer-formaldehyde
and paraffin-embedded. Organ sections of paraffin-embedded
tissues were stained with hematoxylin and eosin (H&E) and
examined by light microscopy. Tubular injury was evaluated by
the presence of alterations in the tubular epithelium, basement
membrane integrity and necrosis. Vascular interstitial congestion
was also assessed. Another group of mice were sacrificed
for immunofluorescence analysis. Mice were anesthetized with
pentobarbital (100 mg/kg) and perfused transcardially with
0.9% NaCl solution followed by 4% paraformaldehyde in 0.1M
phosphate buffer solution [fixative per animal weight (ml/g)].
Brains were removed from the skull, and post-fixed in the same
fixative solution for 2 h. Brain sections were cut on a cryostat.
Serial 20-µm-thick coronal sections were obtained and collected
in 0.1M phosphate buffer solution. The brain floating sections
obtained were processed for bacteriophage, Stx, GFAP or NeuN
immunofluorescence.
Immunofluorescence of Stx2,
Bacteriophage, NeuN, CC1, and GFAP
The brains were processed in a cryostat, and the sections (20µm
each) were kept at 20◦ C in a cryopreservant solution (50%
of PBS plus 30% ethylene glycol plus 20% glycerol) until the
day the different immunofluorescence assays were carried out.
After several rinses with 10mM PBS, brain floating sections were
permeabilized with 0.1% Triton X-100 and blocked with normal
goat serum 10% (Sigma, St. Louis, MO, USA) with the same
buffer solution for 1 h, and immediately incubated (at 4◦C for
48 h) with different primary antibodies (1:500): rabbit anti-Stx2
antibody (1/50; 1.35 mg/ml), mouse anti-bacteriophage 933W,
mouse anti-NeuN (Millipore, Temecula, CA, USA), rabbit anti-
CC1 (Abcam, Cambridge, UK) or rabbit anti-glial fibrillary acidic
protein (GFAP, Dako, Glostrup, Denmark).
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After several rinses with 10mM PBS-X-100 0.025%, the
sections were incubated with the secondary antibodies
(1:500) goat IgG anti-Rabbit Alexa Fluor 555 (Invitrogen
Molecular Probes, Carlsbad, California, USA) for Stx2,
Phage or GFAP immunofluorescence, and goat IgG anti-
mouse/Texas Red (Amersham, GE, Piscataway, NJ, USA) for
NeuN immunofluorescence. All secondary antibodies were
prepared in the same buffer with 0.3% Triton X-100 and
incubated for 2 h at room temperature. Finally, sections were
rinsed with 10mM PBS and mounted on slides. Controls were
performed using the same procedure but without adding the
primary antibody. A positive control was aggregated for the Stx2
inmunofluorescence; these brain sections were analyzed from
Stx-treated mice (1 µg per mice injected intravenously with a
final volume of 100 µl from a 0.01 µg/µl solution).
Analysis of Micrographs
The mean data were obtained from the measurement of the
micrographs of eight sections from four independent brains
per treatment. A confocal laser scanning biological microscope
(Olympus FV10-ASW) was used. The images obtained were
analyzed using Image-J software (NIH, city, USA).
The “cell counter” plugin from Image-J software was
employed to quantify the number of Stx2 immunoreactive
cells and the abnormal NeuN. The criterion to determine the
neuronal-stressed phenotype was the displacement of the nuclear
marker to the cytoplasm. The ROI manager analyzer tool in
Image-J software was employed to quantify the expression of
GFAP and the presence of the bacteriophage, and to determine
reactive astrocytes and whether the phages were present in the
cerebral parenchyma. For this purpose, the color channels of
the micrographs were split by the software, and the red color
channel (now on an 8 bit gray scale format) was selected to
analyze the area of interest. To observe in which CNS cells the
phages were localized, the phage immunofluorescence assay was
followed by that of GFAP (Astrocytes), CC1 (Oligodendrocytes),
NeuN (neurons) and IBA-1 (microglia). Hoechst 33342 (Sigma,
St. Louis, MO, USA) was used (1µg/ml 10min) to show the
cell nuclei in all immunofluorescence assays. The values from
the background observed in all control micrographs of the anti-
GFAP and anti-bacteriophage 933W were subtracted from the
treated mouse micrographs.
Statistical Analysis
The data are presented as mean ± SEM for Stx2
immunofluorescence. Statistical significance was performed
using a one-way analysis of variance (ANOVA) followed by
Tukey’s multiple comparison test between the three tests
(lysogenic C6008933W, C600 and positive control). In the
case of the other three immunofluorescence assays (anti-
bacteriophage 933W, NeuN and GFAP), where there were only
two different treatments (E. coli C600φ933W and E. coli C600),
statistical significance was performed using a t-test (Wilcoxon
matched pair test) with a confidence interval of 95% (GraphPad
Prism 4, GraphPad Software, Inc.). The criterion for significance
was p< 0.05 for all the experiments.
RESULTS
Growth Curves of E. coli C600 and E. Coli
C6008933w
In order to evaluate the growth parameters of the strains
to be used in the infection assays, their growth curves were
analyzed. Figure 1A shows that E. coli C600 (strain used as the
negative control) and E. coli C6008933W (strain lysogenic for
bacteriophage 933W) did not differ significantly between 0 and
15 h. The strains also showed a similar viability count at 16 h,
when cultures were used to prepare the inoculums to infect
mice.
Mice Infected With E. coli C6008933w Died
72h After Infection
Mice infected intragastrically with 2 × 107 CFU/mouse non-
pathogenic C600 strain lysogenized with bacteriophage 933W
(C6008933W) died 72 h post-infection (Figure 1B). Control
mice infected with non-pathogenic E. coli strain C600 remained
healthy for 5 days, after which they were sacrificed.
Mice infected with E. coli C6008933W showed a significant
increase in the plasma urea level compared to mice infected with
E. coli C600 (Figure 1C), demonstrating kidney damage due to
bacteriophage induction and Stx production.
Histology of Kidneys and Intestines of
Mice Infected With E. coli C6008933w
In another set of experiments, groups of mice were infected with
E. coli C6008933W or C600 and sacrificed at 72 h. Kidneys,
intestines and brains of the mice were excised for histological
studies.
Kidneys from mice infected with E. coli C6008933W
showed mesangial proliferation (black arrow in Figures 2A,C),
necrosis and detachment of tubular cells (black arrowhead
in Figures 2A,C), as well as tubular dilation (black asterisk
in Figures 2A,C). Control mice infected with E. coli C600
did not show kidney damage (or presented normal features)
(Figures 2B,D).
Intestines of mice infected with E. coli C6008933W showed
signs of damage, including lymphocytic infiltration in themuscle,
submucosal and mucosal edema in the small intestine (Figure 3),
andmucosal edema in the large intestine (Figures 3F,H). Control
mice infected with E. coli C600 did not show intestinal damage
(Figures 3A,C,E,G).
Immunofluorescence Analysis of Stx2
Expression in Brains
To evaluate the presence of Stx2 in brains from E. coli
C6008933W-infected mice, an immunofluorescence assay using
a polyclonal anti-Stx2 antibody was performed (Tironi-Farinati
et al., 2010). The analyzed area was the motor cortex (Figure 4L).
Immunopositive cells for Stx2 were not found in control mice
infected with E. coli C600 (Figures 4A–C), but were observed in
E. coli C6008933W-treated mice (Figures 4D–F). Also, positive
control mice treated with 1µg of Stx2 showed a higher number
of Stx2-immunopositive cells (Figures 4G–I) compared with E.
coli C6008933W-treated mice (17.73 ± 1.89 C6008933W vs.
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FIGURE 1 | (A) Growth curves of E. coli C600 and E. coli C6008933W. Both strains present a similar growth curve with a non-significant difference between the
viability counts. (B) Survival curve. Survival rates of mice infected with E. coli C6008933W are shown. Mice infected with E. coli C600 were used as controls.
(C) Stx-induced renal damage. Plasmatic urea levels at 72 h post-infection were measured as a parameter of renal damage. Each bar represents the mean ± SEM of
4–6 mice/group. **P = 0.0095.
FIGURE 2 | Kidney histology. Mesangial proliferation is observed in in mice infected with E. coli C6008933W (black arrow in A,C), as well as necrosis and
detachment of tubular cells (black arrowhead in A,C), and tubular dilation (black asterisk in A,C). No effect was observed in mice infected eith the control strain E. coli
C600 (B,D). Periodic acid shift (PAS). Magnification: 200×.
56.6 ± 2.46 positive control cells, Figure 4K). Stx2 was not
immunodetected in the negative controls (Figure 4J).
Immunofluorescence Analysis of
Bacteriophage Detection in Brains
After Stx2 was immunodetected in the brain, the presence of
the bacteriophage containing the sequence for Stx2 was further
determined by immunofluorescence, employing an in-house
polyclonal antibody against bacteriophage 933W. Additionally,
the antibodies anti-CC1, anti-GFAP, anti-NeuN and anti-IBA-
1 were used to identify oligodendrocytes, astrocytes, neurons
and microglia, respectively, to determine which cell type was
immunolabeled with the anti-phage 933W.
Accordingly, bacteriophage 933W was immunolocalized in
the cerebral parenchyma (Figure 5N) in oligodendrocytes in the
white matter of the corpus callosum (Figures 5E–H), and in
GFAP-immunoreactive astrocytes forming the glia limitans of
the ventral hypothalamus (Figures 5I–L). Finally, bacteriophage
933W was not observed in mice infected with E. coli C600
(Figures 5A,C,D) or in negative controls omitting the primary
antibody (Figure 5B). The presence of bacteriophage 933W in
the cerebral parenchyma was quantified: 0.00 C600 vs. 40.051 ±
1.89 C6008933W AU in IOD (Figure 5M).
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FIGURE 3 | Intestine histology. Necrosis is observed in intestinal microvilli (black arrow, B,D) of the small intestine and in the crypt of the large intestine (black arrow in
F,H). There is also marked edema surrounding the crypts of the mucosa and muscle fibers (black asterisk in F,H). (A,C,E,G) corresponding to the control group, did
not present lesions. H&E. Magnification: (A,B and E,F 200×, C,D and G,H) 400×.
Bacteriophage 933W Increased the
Expression of GFAP in Astrocytes
We have previously demonstrated that mammalian cells are
able to express Stx2 after prokaryotic plasmid (pStx2) in vivo
transfection, which led to an increase of GFAP in astrocytes
(Bentancor et al., 2013). Now, bacteriophage 933W was induced
from E. coli C6008933W in vivo to determine whether it
could produce these reactive astrocytes, which are associated
with brain damage. GFAP was significantly up-regulated in
the internal capsule (Figure 6I) of mice infected with E.
coli C6008933 72 h post-infection (Figures 6D–F) compared
with the E. coli C600 treated-mice (Figures 6A–C) (13.63
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FIGURE 4 | Detection of Stx2 in brains of mice infected with E. coli C6008933W. (A–C) A representative brain section from control mouse infected with E. coli C600.
(D–F) Brain section from mouse infected with E. coli C6008933W. (G–I) Brain section from a positive control mouse after 4 days of treatment with 1 µg of Stx2. (J)
Negative control. (K) Number of Stx2-immunopositive cells in in the mouse motor cortex (mc) per micrograph. Stx2 immunopositive cells are indicated by arrows in
(F,I). (L) The area observed is located in the mouse mc. The scale bar in “J” applies to all micrographs.
Frontiers in Microbiology | www.frontiersin.org 6 December 2018 | Volume 9 | Article 3104
Del Cogliano et al. Relevance of Bacteriophage 933W in HUS Development
FIGURE 5 | Bacteriophage detection in brains of mice infected with E. coli C6008933W. (A,C,D) Brain from control mouse infected with E. coli C600. (E,L) Brain from
mouse infected with E. coli C6008933W 72h after inoculation. (E–H) External capsule; (I–L) hypothalamus. (B) Negative control omitting the secondary antibody. (N)
Bacteriophage were detected in the mouse corpus callosum (cc) and hypothalamus (hy) (the red square shows where the micrographs were taken). (M) Quantification
of bacteriophages in the cerebral parenchyma by integral optical density (IOD). lv, lateral ventricle; gl, glia limitans. The scale bar in “B” applies to all micrographs.
± 2.209 C600 vs. 62.77 ± 9.102 C6008933W AU in IOD,
Figure 6H). No immunofluorescence corresponding to GFAP
was found in negative controls omitting the primary antibody
(Figure 6G).
Bacteriophage E. coli C6008933w
Produced Neuronal Damage
It is known that Stx2 induces toxicity in neurons (Fujii et al.,
1994; Goldstein et al., 2007). The neuronal nuclear marker
NeuN was used to determine whether bacteriophage 933W
caused toxicity in neurons. The criterion used to identify
damaged neurons was the ectopic cellular sub-localization of
NeuN (Pinto et al., 2013). A conserved and homogeneous
nuclear immunofluorescence pattern for NeuN confirmed
healthy neurons in control mice infected with E. coli C600
(Figures 7A–C). In contrast, a significant neurodegenerative
perinuclear or cytoplasmic immunofluorescence pattern was
observed in E. coli C6008933W-treated mice (Figures 7D–F)
in comparison with the conserved neurons of E. coli C600
(1.53 ± 0.42 C600 vs. 5.68 ± 0.66 C6008933W cells).
No immunofluorescence corresponding to NeuN was
observed in negative controls omitting the primary antibody
(Figure 7G).
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FIGURE 6 | GFAP expression increased in astrocytes after E. coli C6008933W infection. (A–C) Brain section from control mouse infected with E. coli C600. (D–F)
Brain section from mouse infected with E. coli C6008933W. (G) Negative control omitting the secondary antibody. (H) GFAP expression measured by integral optical
density (IOD). (I) the area observed is located in the mouse internal capsule (ic). The scale bar in “G” applies to all micrographs. *P < 0.005 as calculated by Student’s
t-test.
DISCUSSION
Shiga toxin-producing E. coli has long been recognized as a
principal cause of HUS (Richardson et al., 1988; Karmali, 1989).
More recently, the induction of Stx-encoding bacteriophages
inserted into the STEC genome was found to be critical for
HUS development in an EHEC mouse model (Tyler et al., 2013).
Other studies have reported that bacteriophage induction can be
enhanced by commonly consumed drinks (Pierzynowska et al.,
2018) and inhibited by phenethyl isothiocyanate (Nowicki et al.,
2014).
The aim of the present work was to analyze if Stx-encoding
bacteriophages can cause renal and intestinal damage in absence
of other STEC pathogenicity factors. We therefore used the
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FIGURE 7 | E. coli C6008933W infection produced a NeuN damage pattern in the mouse brain neurons. (A–C) Brain section from control mouse infected with E. coli
C600. (D–F) Brain section from mouse infected with E. coli C6008933W. (G) Negative control omitting the secondary antibody. (H) NeuN quantification showing a
significant increase in the amount of abnormal cellular NeuN immunolocalization in E. coli C6008933W-treated mice (arrow in F) compared with a conserved and
homogeneous nuclear immunofluorescence pattern in E. coli C600-treated mice (asterisk in C). (I) the area observed is located in the mouse motor cortex (mc). The
scale bar in “G” applies for all micrographs. *P < 0.005 as calculated by Student’s t-test.
C6008933W lysogen, because E. coliC600 does not have proteins
implicated in intestinal colonization and damage. The mouse
model described here is based on one previously developed by
Dr. Palermo’s laboratory to analyze renal and intestinal damage
and lethality, using the wild type O157:H7 (EDL933) E. coli
strain (Fernandez-Brando et al., 2014). Mice infected with non-
pathogenic E. coli carrying only a Stx-producing bacteriophage
(E. coli C6008933W) developed renal, intestinal and brain
damage typical of Stx toxicity after STEC infection. It was thus
demonstrated that a pathogenic bacterial background is not
Frontiers in Microbiology | www.frontiersin.org 9 December 2018 | Volume 9 | Article 3104
Del Cogliano et al. Relevance of Bacteriophage 933W in HUS Development
necessary for the development of physiological symptoms typical
of HUS.
In this study, antibiotics were used to cause bacteriophage
933W induction and replication, and Stx production and release
(Zhang et al., 2000;Wagner et al., 2002). Bacteriophage induction
in vivo using antibiotics has been previously reported by our team
(Amorim et al., 2014). Here, we did not include a control without
an inducing agent, because high levels of spontaneous induction
(understood as induction in the absence of an inducing agent)
(Livny and Friedman, 2004) of bacteriophage 8933W have been
described in vitro in an E. coli C6008933W lysogen (Imamovic
and Muniesa, 2012). Therefore, the control used was the E. coli
C600 strain without bacteriophage 933W.
Strikingly, a lethal response of mice infected with E. coli
C6008933W was observed after bacteriophage induction. To
determine whether death was related to Stx, we analyzed typical
physiological alterations triggered by STEC infection, including
an increase in urea level, and intestinal, kidney and brain damage.
STEC infections produce kidney damage, with an increase in
urea level and glomerular and tubular abnormalities (Zotta et al.,
2008). Both these alterations corresponding to Stx toxicity were
observed in mice infected with E. coli C6008933W. In addition,
intestinal and brain damage was studied by histological and
immunohistochemistry assays. Edema was observed in small
and large intestines, as previously reported in mice after STEC
infection (Zotta et al., 2008).
The absence of bacterial pathogenic factors in the E. coli C600
carrying 8933W used in this work allows us to hypothesize
that the damage observed could be associated with free
bacteriophages infecting gut bacteria, which drove bacteriophage
replication and Stx production.
We previously reported that mice injected with a Stx-
expressing plasmid developed CNS injury, showing upregulation
of GFAP expression and a decrease in NeuN expression
(Bentancor et al., 2013). The damage observed in the
current work was similar, but provoked by Stx expressed
by the bacteriophage in absence of a pathogenic bacterial
background. Stx and bacteriophages were detected in brains by
immunohistochemistry. A recent study found bacteriophage
T4 was internalized by human brain microvascular endothelial
cells (hBMec) (Nguyen et al., 2017). Here we report for the first
time the presence of bacteriophages in the brain in vivo after
intragastrical infection with a non-pathogenic strain.
In conclusion, the results of this work show that Shiga toxin-
expressing bacteriophages (STB), in absence of other pathogenic
bacterial factors, provoked intestinal, renal and brain damage
associated with HUS development. We have previously reported
that chitosan (Amorim et al., 2014) and cationic peptides (Del
Cogliano et al., 2017) have the capacity to inhibit STB as
a therapeutic alternative for HUS infection. The new animal
model described here is proposed as a useful tool to study
bacteriophages as a therapeutic target, independently of the
bacterial background, and opens an innovative approach to
treating infections caused by toxin-encoding bacteriophages.
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